Brief: Stenocare Preliminary Guidance For Q4-23 Is DKK 1.7 Mln
Nov 6 (Reuters) - Stenocare A/S STENO.CO :
* UPDATED GUIDANCE: RECORD SALES IN 2023 AND BREAK-EVEN IN 2024
* IS ON TRACK TO ALL TIMES HIGH ACTUAL SALES IN 2023 OF AROUND 6.5MDKK
* THAT SALES ARE EXPECTED TO REACH 15MDKKK IN 2024 (+/-20%) LEADING TO PROJECTED BREAK-EVEN
BY END
2024
* PRELIMINARY SALES GUIDANCE FOR Q4-23 OF 1.7MDKK
Source text for Eikon: ID:nWkr7NkQbS
Further company coverage: STENO.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))